Asia Deal Watch: HanAll, Daewoong Team With US Biotech In Parkinson's
Executive Summary
Sino acquires Gmax's obesity drug candidate. Simcere partners with Mass General Brigham on select research projects.
You may also be interested in...
Unthinkable? Reports That AZ May Spin Off China Ops Amid Geopolitical Risks
AstraZeneca is reportedly considering joining a prominent investment fund to spin off and list its Chinese entities, in an apparent bid to better insulate them against potential geopolitical risks.
Samsung Biologics Strikes $400m+ Biosimilars Supply Deal With Pfizer
Samsung Biologics has struck a deal worth over $400m to manufacture multiple biosimilars for Pfizer.
Indoco Builds On Recent Growth With Acquisition In US
Indoco says it has marked a major milestone with a $4m deal to take a controlling stake in US firm Florida Pharmaceutical Products, strengthening the Indian company’s position in the US market.